These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 27835864)

  • 21. Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.
    Berrazouane S; Boisvert M; Salti S; Mourad W; Al-Daccak R; Barabé F; Aoudjit F
    Cell Death Dis; 2019 May; 10(5):357. PubMed ID: 31043590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
    Kunou S; Shimada K; Takai M; Sakamoto A; Aoki T; Hikita T; Kagaya Y; Iwamoto E; Sanada M; Shimada S; Hayakawa F; Oneyama C; Kiyoi H
    Oncogene; 2021 Jun; 40(23):3989-4003. PubMed ID: 33994542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.
    Agnusdei V; Minuzzo S; Frasson C; Grassi A; Axelrod F; Satyal S; Gurney A; Hoey T; Seganfreddo E; Basso G; Valtorta S; Moresco RM; Amadori A; Indraccolo S
    Leukemia; 2014 Feb; 28(2):278-88. PubMed ID: 23774673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.
    Chiarini F; Grimaldi C; Ricci F; Tazzari PL; Evangelisti C; Ognibene A; Battistelli M; Falcieri E; Melchionda F; Pession A; Pagliaro P; McCubrey JA; Martelli AM
    Cancer Res; 2010 Oct; 70(20):8097-107. PubMed ID: 20876803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.
    Poglio S; Lewandowski D; Calvo J; Caye A; Gros A; Laharanne E; Leblanc T; Landman-Parker J; Baruchel A; Soulier J; Ballerini P; Clappier E; Pflumio F
    Oncotarget; 2016 Jul; 7(27):41599-41611. PubMed ID: 27191650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
    Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
    Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncanonical TGFβ Pathway Relieves the Blockade of IL1β/TGFβ-Mediated Crosstalk between Tumor and Stroma: TGFBR1 and TAK1 Inhibition in Colorectal Cancer.
    Guillén Díaz-Maroto N; Sanz-Pamplona R; Berdiel-Acer M; Cimas FJ; García E; Gonçalves-Ribeiro S; Albert N; Garcia-Vicién G; Capella G; Moreno V; Salazar R; Villanueva A; Molleví DG
    Clin Cancer Res; 2019 Jul; 25(14):4466-4479. PubMed ID: 30979739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
    Marchesini M; Gherli A; Montanaro A; Patrizi L; Sorrentino C; Pagliaro L; Rompietti C; Kitara S; Heit S; Olesen CE; Møller JV; Savi M; Bocchi L; Vilella R; Rizzi F; Baglione M; Rastelli G; Loiacono C; La Starza R; Mecucci C; Stegmaier K; Aversa F; Stilli D; Lund Winther AM; Sportoletti P; Bublitz M; Dalby-Brown W; Roti G
    Cell Chem Biol; 2020 Jun; 27(6):678-697.e13. PubMed ID: 32386594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance.
    Yan ZX; Zheng Z; Xue W; Zhao MZ; Fei XC; Wu LL; Huang LM; Leboeuf C; Janin A; Wang L; Zhao WL
    Biomed Res Int; 2015; 2015():197241. PubMed ID: 26436088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
    Guo Y; Shan QQ; Gong YP; Lin J; Yang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AKR1C enzymes sustain therapy resistance in paediatric T-ALL.
    Bortolozzi R; Bresolin S; Rampazzo E; Paganin M; Maule F; Mariotto E; Boso D; Minuzzo S; Agnusdei V; Viola G; Te Kronnie G; Cazzaniga G; Basso G; Persano L
    Br J Cancer; 2018 Apr; 118(7):985-994. PubMed ID: 29515258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carmustine-resistant cancer cells are sensitized to temozolomide as a result of enhanced mismatch repair during the development of carmustine resistance.
    Yamauchi T; Ogawa M; Ueda T
    Mol Pharmacol; 2008 Jul; 74(1):82-91. PubMed ID: 18430789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
    Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
    Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of stroma-supported cultures of leukemic cells to assess antileukemic drugs. II. Potent cytotoxicity of 2-chloro-deoxyadenosine in acute lymphoblastic leukemia.
    Kumagai M; Manabe A; Coustan-Smith E; Blakley RL; Beck WT; Santana VM; Behm FG; Raimondi SC; Campana D
    Leukemia; 1994 Jul; 8(7):1116-23. PubMed ID: 7913512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth.
    Guan X; LaPak KM; Hennessey RC; Yu CY; Shakya R; Zhang J; Burd CE
    Mol Cancer Res; 2017 Mar; 15(3):237-249. PubMed ID: 28039358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The depletion of PHF6 decreases the drug sensitivity of T-cell acute lymphoblastic leukemia to prednisolone.
    Xiang J; Wang G; Xia T; Chen Z
    Biomed Pharmacother; 2019 Jan; 109():2210-2217. PubMed ID: 30551478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
    Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
    Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Methoxyestradiol blocks cell-cycle progression at the G2/M phase and induces apoptosis in human acute T lymphoblastic leukemia CEM cells.
    Zhang X; Huang H; Xu Z; Zhan R
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):615-22. PubMed ID: 20732853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples.
    Lu BY; Thanawala SU; Zochowski KC; Burke MJ; Carroll WL; Bhatla T
    Leuk Lymphoma; 2016 Aug; 57(8):1938-41. PubMed ID: 26726842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.